We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AON:NYSEAon plc Analysis

Data as of 2026-05-23 - not real-time

$324.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Aon plc trades at $324.78, comfortably above its 20‑day SMA of $317.38 and 50‑day SMA of $321.59, yet still below the 200‑day SMA of $341.88, signaling a short‑term upside potential within a longer‑term bearish backdrop. The MACD histogram is positive (+1.52) and the line sits above the signal, reinforcing bullish momentum, while the RSI at 54.8 suggests the stock is neither overbought nor oversold.
Volatility is elevated at 25% over the past 30 days and beta is modest (~0.71), indicating market‑wide swings but limited systematic risk. Fundamentals remain strong: revenue grew 6.5% YoY, ROE is an impressive 46%, operating margin stands at 35.8% and free cash flow exceeds $3.3 bn, supporting a sustainable dividend yield of 1% with a low 16% payout ratio. However, the current price is well above the DCF‑derived fair value of $202 and its PE of 17.8 exceeds the industry average of 16.8, suggesting the stock is overvalued despite the positive earnings outlook. Recent material news – the launch of the Aon Digital Placement Exchange (DPX) and an analyst upgrade to a $388 target – adds upside catalysts, but the overall valuation gap tempers enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs but below long‑term SMA
  • Bullish MACD histogram with neutral RSI
  • Support at $306.5 and resistance at $330.2

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high ROE
  • Robust cash flow supporting dividend sustainability
  • Analyst target price uplift and new DPX platform launch

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Overvaluation relative to DCF fair value
  • Consistent profitability and low payout ratio
  • Diversified global footprint mitigating geographic risk

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin22.54%
P/E Ratio17.8
ROE46.45%
ROA6.05%
Debt/Equity155.05
P/B Ratio7.1
Op. Cash Flow$3.8B
Free Cash Flow$3.3B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI54.8
Support$306.52
Resistance$330.22
MA 20$317.38
MA 50$321.59
MA 200$341.88
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$202.05
Target Price$384.84
Upside/Downside18.49%
GradeOvervalued
TypeGrowth
Dividend Yield1.01%

Risk Assessment

Beta0.04
Volatility25.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.